BRUKER CORP

(1)

The amounts in this column reflect the grant date fair value of awards of RSUs, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. The actual amount realized by the named executive officer will vary based on several factors, including our performance, stock price fluctuations and applicable vesting. Dividends are paid on all shares of stock at the standard rate as approved by our Board of Directors.

(2)

The amounts in this column reflect the grant date fair value of stock option awards, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. Assumptions used in the calculations of these amounts may be found in Note 2 to our 2024 audited financial statements included in our Annual Report on Form 10-K filed with the SEC on March 3, 2025. The actual amount realized by the named executive officer will vary based on several factors, including our performance, stock price fluctuations and applicable vesting.

(3)

Non-Equity Incentive Plan Compensation for all executives is calculated using a prorated bonus target, which reflects the changes in base pay and incentive targets implemented during the fiscal year. Merit increases that were effective April 1, 2024, increased the base and target incentive for the remainder of 2024.

(4)

Reflects matching contributions made under our 401(k) plan, automobile allowance, dividend equivalent units paid, and/or pension contributions for each of our named executive officers in 2024.

(5)

The amounts reflected for 2024 compensation, other than amounts reported under the headings “Stock Awards”, “Option Awards”, and “Non-Equity Incentive Plan Awards”, are based on actual payments in Swiss francs converted to U.S. dollars at a conversion rate of CHF 1.0 =$1.136, which represents the 2024 average midpoint rate. The amounts reflected under the heading “Non-Equity Incentive Plan Awards” are converted from Swiss francs to U.S. dollars at a conversion rate equal to the midpoint rate on the date of approval by the Compensation Committee of CHF 1.0 =$1.107. In addition to the annual equity award, Mr. Busse received a special recognition grant of $50,000 for outstanding performance relating to an acquisition.

(6)

The amounts reflected for 2024 compensation, other than amounts reported under the headings “Stock Awards”, “Option Awards”, and “Non-Equity Incentive Plan Awards”, are based on actual payments in euros converted to U.S. dollars at a conversion rate of €1.0 =$1.082, which represents the 2024 average midpoint rate. The amounts reflected under the heading “Non-Equity Incentive Plan Awards” are converted from euros to U.S. dollars at a conversion rate equal to the midpoint rate on the date of approval by the Compensation Committee of €1.0=$1.045.

(7)

Amount includes an additional cash compensation payment to Dr. Munch of $300,000 in connection with his role as CEO of the Company’s majority-owned startup company, Acuity Spatial Genomics, earned in 2024 and paid in 2025.

(8)

In addition to the annual equity award, Mr. Munch received a special recognition grant of $100,000 for outstanding performance relating to an acquisition.

(9)

The amount reflects a payment that was part of an inflation support program provided to all Bruker Daltonics GmbH & Co.KG employees, converted to USD using €1.0 =$1.082, which represents the 2024 average midpoint rate.

(10)

Pursuant to Mr. Srega’s MDE Contract, for retention purposes Mr. Srega was awarded larger than typical long-term incentive equity awards in each of 2020, 2021, 2023 and 2024. Portions of the grants were allocated to performance in 2022 and are expected to be allocated to performance in 2025, 2026, and 2027. Accordingly, in 2022, Mr. Srega’s long-term incentive equity award was relatively lower than typical to take the larger awards expected to be granted into account. Similarly, the 2025, 2026, and 2027 grants are also planned to be relatively lower than typical to take the larger awards into account. The amount shown in this table represents the derived annualized amount for Mr. Srega's awards. In addition to the annual equity award, Mr. Srega received a special recognition grant of $100,000 for outstanding performance relating to an acquisition.

(11)

Starting in 2020, the pension scheme no longer had a cap on Company contributions and therefore Mr. Srega stopped contributing to his pension at that time. Due to scrivener's error, the amount for "All other compensation" in this table was under-reported for the years 2020 through 2023 by approximately $3,000 for each year.